The F-box protein 8 (FBXO8), a member of the F-box protein family, plays a critical role in the ubiquitin-protein ligase complex, leading to protein degradation. The ubiquitin-protein ligase complex is an essential component of the ubiquitin-proteasome system, a pathway responsible for protein degradation, cell cycle regulation, and numerous other cellular processes. FBXO8, in particular, has been implicated in various aspects of cellular function and has been studied in the context of several biological processes, including cancer progression. However, it is important to note that the understanding of FBXO8's function, regulation, and the mechanisms by which it contributes to cellular processes is still evolving.
While the exact mechanisms of regulation of FBXO8 expression are not fully understood, several chemical compounds could induce its expression. Substances such as retinoic acid, 5-Aza-2'-deoxycytidine, and trichostatin A, which are known to generally promote gene expression, can induce FBXO8 expression. Similarly, histone deacetylase inhibitors like sodium butyrate, vorinostat, and entinostat may also increase FBXO8 expression, given their ability to induce gene expression. DNA methyltransferase inhibitors, including disulfiram, zebularine, decitabine, and procainamide, which can reactivate silenced genes and upregulate gene expression, may also influence FBXO8 expression. However, it is crucial to note that these relationships are purely speculative, and rigorous scientific research is needed to confirm these hypotheses. Ultimately, the study of FBXO8, its regulation, and its functional implications remains a dynamic and developing field of research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of Vitamin A, is involved in upregulating gene expression and cell differentiation, potentially inducing FBXO8 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This DNA methyltransferase inhibitor can upregulate gene expression broadly, potentially inducing FBXO8 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can upregulate gene expression, potentially inducing FBXO8 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can induce gene expression, potentially leading to increased FBXO8 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a nucleoside metabolic inhibitor that can upregulate gene expression by demethylation, potentially inducing FBXO8 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid is a histone deacetylase inhibitor and can induce gene expression, potentially leading to increased FBXO8 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit DNA methyltransferase and reactivate silenced genes, potentially upregulating FBXO8 expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine is a cytidine analog containing a 2(1H)-pyrimidinone ring and acts as a DNA methyltransferase inhibitor, potentially upregulating FBXO8 expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is a histone deacetylase inhibitor and can induce gene expression, potentially leading to increased FBXO8 expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 is a non-nucleoside DNA methyltransferase inhibitor that can upregulate gene expression, potentially inducing FBXO8 expression. | ||||||